You are here

  • Home
  • Archive
  • Volume 13, Issue 9
  • Cost–utility analysis of commonly used anti-glaucoma interventions for mild-to-moderate primary open-angle glaucoma patients in rural and urban China

Article info

Article menu
Ophthalmology
Original research
Cost–utility analysis of commonly used anti-glaucoma interventions for mild-to-moderate primary open-angle glaucoma patients in rural and urban China

Authors

  • Ruyue Li Beijing Institute of Ophthalmology, Beijing, ChinaBeijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing, China PubMed articlesGoogle scholar articles
  • Kaiwen Zhang Beijing Institute of Ophthalmology, Beijing, ChinaBeijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing, China PubMed articlesGoogle scholar articles
  • Zhecheng Lu Beijing Institute of Ophthalmology, Beijing, ChinaBeijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing, China PubMed articlesGoogle scholar articles
  • Dapeng Mou Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing, China PubMed articlesGoogle scholar articles
  • Jin Wang Beijing Institute of Ophthalmology, Beijing, ChinaBeijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing, China PubMed articlesGoogle scholar articles
  • Huiqi Li School of Medical Technology, Beijing Institute of Technology, Beijing, China PubMed articlesGoogle scholar articles
  • Sujie Fan Handan City Eye Hospital, Handan, China PubMed articlesGoogle scholar articles
  • Ningli Wang Beijing Institute of Ophthalmology, Beijing, ChinaBeijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing, China PubMed articlesGoogle scholar articles
  • Hanruo Liu Beijing Institute of Ophthalmology, Beijing, ChinaBeijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing, China PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Hanruo Liu; hanruo.liu{at}hotmail.co.uk; Professor Ningli Wang; wningli{at}vip.163.com
View Full Text

Citation

Li R, Zhang K, Lu Z, et al
Cost–utility analysis of commonly used anti-glaucoma interventions for mild-to-moderate primary open-angle glaucoma patients in rural and urban China
BMJ Open 2023;13:e073219. doi: 10.1136/bmjopen-2023-073219

Publication history

  • Received March 7, 2023
  • Accepted August 20, 2023
  • First published September 6, 2023.
Online issue publication 
March 26, 2024
Previous versions
Review history

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.